Severe Malaria in Remote Areas- Closing the Evidence Gap

NCT06806956 · clinicaltrials.gov ↗

ENROLLING_BY_INVITATION

Status

2016

Enrollment

OTHER_GOV

Sponsor class

Conditions

Severe Malaria

Interventions

DRUG: Treatment of severe malaria with either RAS + ACT or RAS + injectable artesunate + ACT will each achieve the clinically acceptable cure rate of 97% ± 5% in remote areas

Sponsor

Tropical Diseases Research Centre, Zambia

Collaborators

[object Object]
[object Object]
[object Object]
[object Object]
[object Object]